Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / General / General / April 2006

Tip: Looking for answers? Try searching our database.

Novel brain-penetrating antioxidant

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
ironjustice@aol.com - 27 Apr 2006 15:18 GMT
Since the PROBLEM with the anti-psychotics IS the .. buildup of iron ..
then one might think the 'novel brain-targeted antioxidant ' .. might
be an iron .. chelator.

Clin Neuropharmacol. 2005 Nov-Dec;28(6):285-8. Related Articles, Links

A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced
abnormal movement in rats: implications for tardive dyskinesia.

Sadan O, Bahat-Stromza M, Gilgun-Sherki Y, Atlas D, Melamed E, Offen D.

Department of Neurology and Felsenstein Medical Research Center, Rabin
Medical Center, Petah Tikva, 49100 Israel.

BACKGROUND: Tardive dyskinesia (TD), characterized by abnormal
movements, is the major late-onset chronic side effect of antipsychotic
treatment found in about 30% of those patients. The association of
oxidative stress and the release of free radicals is one of the
hallmarks of dopaminergic malfunctions and is one of the leading
theories suggested for the pathophysiology of TD. To this day, no
brain-targeted antioxidant has been tested as a potential treatment of
TD. In light of this assumption, the authors chose a novel,
low-molecular weight thiol antioxidant, N-acetyl cysteine amide (AD4),
that crosses the blood-brain barrier as a possible treatment of TD.
OBJECTIVE: To examine the protective effects of the novel
brain-penetrating antioxidant AD4 on TD experimental models. METHODS:
The typical vacuous chewing movement occurs in rats following chronic
haloperidol injections (1.5 mg/kg/day intraperitoneally for 21 days).
This purposeless mouth opening in the vertical plane is similar to TD
symptoms in humans. The authors tested rats treated with haloperidol
without or with AD4 in the drinking water (1 g/kg orally).
Thiobarbituric acid reactive substances and anticarbonyl antibodies
were used to measure oxidation of membranes and proteins. RESULTS:
Haloperidol increased the vacuous chewing movements to 66.5 +/- 7.6
movements/5 minutes compared with 16.4 +/- 2.4 movements/5 minutes in
untreated rats (P < 0.01). Coadministration of haloperidol and AD4
decreased the vacuous chewing movements level to 42.1 +/- 6.7
movements/5 minutes (P < 0.05). Haloperidol also increased the level of
lipid peroxidation and protein oxidation in the rat brain, whereas
coadministration with AD4 preserved their normal levels. CONCLUSION:
Haloperidol causes behavioral abnormalities associated with oxidative
stress in rats, similar to TD. AD4, the brain-targeted potent
antioxidant, reduces the cellular oxidation markers and improves the
typical clinical behavior. Hence, AD4 is a potential new treatment of
antipsychotic-induced TD.

PMID: 16340385 [PubMed - indexed for MEDLINE]

--------------------------------------------------------------------------------

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore

DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking
outsor@citynet.net - 27 Apr 2006 15:32 GMT
"S"

No, tk is not the build up of iron.
ironjustice@aol.com - 28 Apr 2006 10:52 GMT
">>S"

No, tk is not the build up of iron.<<

Isr J Med Sci 1993 Sep;29(9):587-92

Iron modulates neuroleptic-induced effects related to the dopaminergic
system.

Ben-Shachar D, Livne E, Spanier I, Zuk R, Youdim MB
Department of Pharmacology, B. Rappaport Faculty of Medicine, Technion
Haifa,
Israel.

Long-term neuroleptic medication to schizophrenic patients is often
associated
with extrapyramidal side effects, of which tardive dyskinesia is the
most
severe. The mechanism by which neuroleptics induce these side effects
is
unclear. The dopaminergic system is the main target with which the
neuroleptics
interact in the brain. Intact dopaminergic function is dependent on
normal
iron
metabolism. Thus, the relationship between iron and the neuroleptics
may
elucidate some new aspects of their mechanism of action. Indeed,
peripheral
iron status plays a crucial role in neuroleptic-induced dopamine
supersensitivity. Moreover, neuroleptics such as haloperidol and
chlorpromazine, alter the blood brain barrier (BBB) of the rat and
enhance
the
normally restricted iron transport into the brain. Increased brain iron

levels
may be related to the toxic effects of these drugs since clozapine, an
atypical
neuroleptic with a low incidence of extrapyramidal side effects,
prohibits
iron
uptake into the brain but causes sedimentation of iron in brain blood
vessels.
The demonstration that peripheral iron concentrations affect
neuroleptic-induced dopamine receptor supersensitivity as well as iron
transport into the brain may have therapeutic significance. In
addition, the
different potentials of typical and atypical neuroleptics to increase
iron
transport into the brain may be related to the severity of the side
effects
they induce and to the pathophysiology of tardive dyskinesia.

Publication Types:

Review
Review, tutorial

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore

DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking
Mr. Natural-Health - 27 Apr 2006 15:49 GMT
> Since the PROBLEM with the anti-psychotics IS the .. buildup of iron ..
> then one might think the 'novel brain-targeted antioxidant ' .. might
> be an iron .. chelator.

anti-psychotics???

Preaching to the choir?

Gee, I bet all the psychotics in these ngs with thank you forever. :(

Ha, ... Hah, Ha!!!

Are there any NON-kooks on these ngs?
Mr. Natural-Health - 27 Apr 2006 15:53 GMT
ironjustice@aol.com wrote:
> Since the PROBLEM with the anti-psychotics IS the .. buildup of iron ..
> then one might think the 'novel brain-targeted antioxidant ' .. might
> be an iron .. chelator.

anti-psychotics???

Preaching to the choir?

Gee, I bet all the psychotics in these ngs will thank you forever. :(

Ha, ... Hah, Ha!!!

Are there any NON-kooks on these ngs?
Marshall Johnston - 28 Apr 2006 03:34 GMT
> ironjustice@aol.com wrote:
>> Since the PROBLEM with the anti-psychotics IS the .. buildup of iron ..
[quoted text clipped - 10 lines]
>
> Are there any NON-kooks on these ngs?

Don't you hate it with you make those kind of mistakes?
Quiet Neighbor - 29 Apr 2006 15:36 GMT
Neuroleptics are commonly called
"anti-psychotics."
Did I miss a spelling error?

> > ironjustice@aol.com wrote:
> >> Since the PROBLEM with the anti-psychotics IS the .. buildup of iron ..
[quoted text clipped - 12 lines]
>
> Don't you hate it with you make those kind of mistakes?

Rate this thread:






 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.